Desq Long
Sign in
SEC FORM 4
$102,972.78

Aktis Oncology, Inc. (AKTS)

Sale of 5,099 shares at $20.1947 per share.

Reporting Person Czibere Akos · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401014 · filed 2026-09-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Aktis Oncology, Inc. (AKTS)." Disclosed 2026-09-24. https://desqlong.com/cards/0001193125-26-401014-2 (retrieved 2026-09-26).